UroToday

Association between Neurogenic Bladder Symptom Score and Disability Status in Multiple Sclerosis Patients.

Multiple sclerosis (MS) is a chronic neurodegenerative disease that frequently causes neurogenic lower urinary tract dysfunction (NLUTD). More than 75% of patients experience urinary symptoms that ...
UroToday

Preclinical Study Evaluates p300 Protein in AR-Driven Prostate Cancer - Jie Luo

Zachary Klaassen speaks with Jie Luo about his Prostate Cancer Foundation Young Investigator Award work on androgen receptor enhanceosomes in prostate cancer. Dr. Luo explains that enhanceosomes are ...
UroToday

First Use of the FloStent™ for Catheter-Dependent Urinary Retention Secondary to BPH: Additional Results from the RAPID I Study - Beyond the Abstract

In our RAPID I pilot study, we evaluated the FloStent™, a self-expanding nitinol prostatic stent, as a bridge therapy for men with benign prostatic hyperplasia (BPH) and catheter-dependent urinary ...
UroToday

Antibiotic-Augmented Irrigation During Ureteroscopy in High-Risk Patients "Presentation" - Kriselle Madamba

At the World Congress of Endourology and Uro-Technology, Kriselle Madamba presented research on antibiotic-augmented irrigation using neomycin and polymyxin B during ureteroscopy to reduce ...
UroToday

Comparing Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia - Dean Elterman

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
UroToday

DARPin-Based Radioligand Therapy Targets DLL3 with Lead-212 for Cancer Treatment - Philippe Legenne

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
UroToday

Holmium and Thulium Fiber Lasers: What You Need to Know.

Laser technology has rapidly propelled surgical techniques in urinary tract calculus removal. The thulium fiber laser (TFL) is a relatively new tool that can be used for laser lithotripsy, as an ...
UroToday

Real-World Implementation of Biomarkers for Microhematuria Workup - Ronald Loo & Christopher Filson

Zachary Klaassen interviews Ron Loo and Chris Filson about integrating the urine‑based Cxbladder Triage test into microscopic hematuria evaluation across their large health system. The retrospective ...
UroToday

TROP2 as Alternative Target for Metastatic Prostate Cancer Imaging and Therapy "Presentation" - Tanya Stoyanova

At the 2025 UCSF-UCLA PSMA Conference, Tanya Stoyanova discusses TROP2 as a promising alternative target for prostate cancer imaging and radiotherapy. She highlights that 25% of metastatic ...
UroToday

Predicting BCG Therapy Response in High-Grade Non-Muscle Invasive Bladder Cancer - Weranja Ranasinghe

Read the Full Video Transcript Ashish Kamat: Hello everybody, and welcome to UroToday's Bladder Cancer Center of Excellence. I'm Ashish Kamat, professor of urologic oncology at M.D. Anderson Cancer ...
UroToday

Dry Mouth Prevention and Management for PSMA Radioligand Therapy "Presentation" - Sue Yom

Read the Full Video Transcript Sue Yom: Hi, everybody. As they say on the Monty Python show, “And now for something completely different.” I do appreciate the engagement of patient concerns, and I ...
UroToday

Can We Kill the Bone Scan? "Presentation" - Daniel Spratt

At the 2025 UCSF-UCLA PSMA Conference, Daniel Spratt presents on bone scan obsolescence in prostate cancer imaging. He demonstrates they fail to detect cancer with sufficient sensitivity compared to ...